Research compound comparison · research use
TB-500 vs BPC-157: long chain vs 15-mer.
TB-500 and BPC-157 are the two most cross-searched repair-peptides, so buyers compare them constantly — but they aren't the same kind of molecule. BPC-157 is a short, single-sequence synthetic pentadecapeptide of 15 amino acids; TB-500 is derived from thymosin beta-4, a much longer chain, and is sold as either the full sequence or a short fragment of it. That size difference — and the molecular-weight check it forces on the TB-500 COA — is the whole comparison. This page lays out what each is, the documentation standard behind both, and what to confirm before sourcing either.
| Attribute | TB-500 | BPC-157 |
|---|---|---|
| Class | Thymosin beta-4-derived peptide (actin-binding region) | Synthetic pentadecapeptide (partial BPC sequence) peptide |
| Approximate size | Long-chain — supplied as the full ~43-residue thymosin beta-4 sequence or the short active fragment, depending on supplier | Short-chain — 15 amino acids, a single defined sequence |
| Why molecular weight is the key check | Because “TB-500” is used for two different molecules (full thymosin beta-4 vs the truncated active fragment), the COA mass is what tells you which one is in the vial | One defined 15-mer, so the COA mass should match a single expected value with little ambiguity |
| Identity confirmation studied | Mass spectrometry to confirm full-length vs fragment, plus HPLC purity | Mass spectrometry against the single expected 15-mer mass, plus HPLC purity |
| Why they're compared | Both are the canonical “repair / recovery research” pairing and are almost always cross-searched together as a stack question | Same — BPC-157 is the short-chain half of the same recovery-research pairing |
| Titan format | TB-500 research vial, lyophilized for reconstitution, lot-matched documentation | BPC-157 research vial and nasal-spray format, lyophilized/solution, lot-matched documentation |
| Documentation | Lot-matched release sheet, HPLC purity target with identity confirmation | Lot-matched release sheet, HPLC purity target with identity confirmation |
A long chain vs a short 15-mer
The structural distinction researchers care about: BPC-157 is a short synthetic pentadecapeptide — 15 amino acids in one defined sequence — while TB-500 is derived from thymosin beta-4, a much longer chain, and is sold as either the full ~43-residue protein or only its short actin-binding fragment. They are not the same size of molecule and are not interchangeable. Titan handles both strictly as research compounds, never as substitutes for one another or for any approved medication.
View BPC-157→On TB-500, read the molecular weight first
The single biggest sourcing trap in this pair is that “TB-500” is a trade name used for two different molecules: the complete thymosin beta-4 sequence, and a shorter truncated fragment of it. Those carry very different masses, so the mass on the release sheet — not the label — is what tells you which one you actually received. Confirm the reported molecular weight against the form the supplier claims to ship before trusting anything else on the page.
View TB-500→Same documentation standard for both
Whichever compound you're sourcing, the paper-trail standard does not change: a lot-matched in-house release sheet referenced to the lot code on the unit, against an HPLC purity target with identity confirmation by mass. For BPC-157 that mass is a single expected 15-mer value; for TB-500 it resolves the full-length-vs-fragment question. That consistency is what separates a documented supplier from a blind one — and it is the only claim Titan makes about these compounds.
How to verify a COA→Choose by the sequence your model needs
Pick by what your research model is built around: a short, single-sequence pentadecapeptide points to BPC-157; the thymosin beta-4 actin-binding region points to TB-500 — and there, confirm whether your protocol expects the full chain or the fragment. Avoid any supplier that attaches healing, injury-recovery, dosing, or human-use claims to either; that marketing language is a compliance red flag, not science. For another short-chain repair comparison, see GHK-Cu vs BPC-157.
Compare GHK-Cu vs BPC-157→See the product pages.
Open the TB-500 research vial for size, lot documentation, and crypto checkout, check the BPC-157 vial and nasal-spray formats, or browse the full research catalog.
Compare research compounds
Other peptide comparisons researchers run before sourcing.
Each Titan comparison breaks down the structural differences, research format, and documentation a buyer should confirm — lot-matched COA, HPLC purity target, and a clear research-use boundary. Pick the pair you're evaluating.
GLP-1 / metabolic research
Growth-hormone secretagogue research
Recovery & repair research
Neuropeptide & nasal-format research